Speaking at a press conference, CellProthera’s CEO said the company is moving into the final phase of clinical development ...

In the meantime current gene therapies remain expensive and challenging to scale up because each patient’s batch of cells has ...

Gene and cell therapies bring fresh hope to people with genetic disorders, but recovery can be complex and long-term support ...

Hyperbaric oxygenation (HBOT ) is proving to be a game-changer in regenerative medicine, especially when it comes to boosting stem cell production. In groundbreaking research by Professor Stephen Thom ...

Stem cell transplantation offers promising solutions for tissue regeneration and age-related degeneration, despite challenges ...

The cardiac tissue engineering market is expected to grow from USD 621.2 million in 2024 to USD 1,333.6 million by 2029, ...

Researchers pinpoint a cellular process called 'clonal hematopoiesis' as a new risk factor for cardiovascular problems. In ...

There's new hope for people with sickle cell disease which affects mainly African Americans. It's gene therapy research at ...

FAO is catalyzed by the mitochondrial trifunctional protein (MTP) and, if overloaded, generates ROS. ROS are boosted during ...

According to a research report published by , Companies covered: Vet-Stem, Stemedica Cell Technologies, Stem Cell Therapeutics, Vet Regen, Animal Regenerative Medicine International (ARMI), Mesoblast, ...

The cardiac tissue engineering market is expected to grow from USD 621.2 million in 2024 to USD 1,333.6 million by 2029, ...